- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Absci Prepares for Next Stage of Growth with Two Key Hires
Absci Corporation, the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced two senior executive hires in newly created roles as it prepares for its next stage of growth.
Jack Gold becomes Chief Marketing Officer and Denise Dettore joins as Chief People Officer.
Gold joins as Chief Marketing Officer to build and lead Absci’s marketing team and efforts. Gold was previously Chief Marketing Officer at Zymergen. Prior to Zymergen he spent 21 years at Nike serving in multiple senior marketing roles to help build the brand worldwide. Gold started his career in London at Saatchi & Saatchi, an eminent global advertising firm.
Dettore joins Absci with 26 years of experience in Human Resources in Silicon Valley, 10 years of which were in high-tech companies including Hewlett-Packard and Electronic Arts. For the past 16 years she has been working in the biotech industry, spending time at Genentech, Jazz Pharmaceuticals and BeiGene.
Beyond the Scrubs: Understanding Healthcare Providers as People for Increased Engagement
March 28th 2024The benefits of adopting a humanized approach to healthcare provider marketing extend across the healthcare spectrum, enhancing engagement rates, brand loyalty, and marketing ROI, while also driving better outcomes for patients.
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.
